Vanguard Group’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,400
| Closed | -$7.15K | – | 4606 |
|
|
2023
Q1 | $7.15K | Sell |
2,400
-7,909
| -77% | -$23.6K | ﹤0.01% | 4545 |
|
|
2022
Q4 | $51.6K | Sell |
10,309
-6,352
| -38% | -$31.8K | ﹤0.01% | 4444 |
|
|
2022
Q3 | $108K | Buy |
16,661
+3,905
| +31% | +$25.3K | ﹤0.01% | 4484 |
|
|
2022
Q2 | $93K | Sell |
12,756
-3,144
| -20% | -$22.9K | ﹤0.01% | 4556 |
|
|
2022
Q1 | $234K | Sell |
15,900
-14,580
| -48% | -$215K | ﹤0.01% | 4516 |
|
|
2021
Q4 | $1.46M | Buy |
30,480
+1
| +0% | +$48 | ﹤0.01% | 4150 |
|
|
2021
Q3 | $4.45M | Sell |
30,479
-40
| -0.1% | -$5.84K | ﹤0.01% | 3732 |
|
|
2021
Q2 | $3.52M | Buy |
30,519
+11,673
| +62% | +$1.35M | ﹤0.01% | 3766 |
|
|
2021
Q1 | $1.82M | Buy |
+18,846
| New | +$1.82M | ﹤0.01% | 3884 |
|